Fulvestrant bulk supplier for pharma manufacturers

Fulvestrant 250 mg/5 mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 250 mg/5 mL

Reference Brands: Faslodex (EU & US),Fulzos (India)

Fulvestrant is an injectable oncology drug used to treat hormone receptor-positive breast cancer. Available as 250 mg/5 mL IM injection in the US and EU.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Fulvestrant is a potent estrogen receptor antagonist used in the treatment of HR+ metastatic breast cancer in postmenopausal women. It is indicated for patients whose cancer has progressed after prior endocrine therapy. Marketed as Faslodex®, Fulvestrant is available in both the US and EU as a 250 mg/5 mL intramuscular injection, typically administered as 500 mg monthly. It works by binding and degrading estrogen receptors, thereby inhibiting cancer cell growth. Widely used in oncology hospitals and cancer centers, Fulvestrant is a valuable product for B2B pharmaceutical distribution in the oncology and specialty injectable segments.

Fulvestrant — third party manufacturing & bulk supply

Fulvestrant 250 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fulvestrant is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fulvestrant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fulvestrant →

Back to Listing

Frequently Asked Questions

Fulvestrant is used in the treatment of hormone receptor-positive metastatic or locally advanced breast cancer in postmenopausal women. It is commonly used in patients whose cancer has progressed after treatment with other hormonal therapies such as tamoxifen or aromatase inhibitors.

Fulvestrant is a synthetic estrogen receptor antagonist that binds to estrogen receptors and blocks the effects of estrogen on breast cancer cells, helping to slow or stop the growth of hormone-dependent tumors.

The most widely known trade name is Faslodex.

The original brand Faslodex was developed and marketed by AstraZeneca. Many pharmaceutical companies now manufacture generic versions globally.

The generic name is Fulvestrant.

Brand names include Faslodex and several generic branded versions available in different markets.

Fulvestrant injections are manufactured in several countries including the United States, the United Kingdom, India, and other EU pharmaceutical manufacturing hubs depending on the manufacturer.